These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16295291)

  • 1. Physicians' knowledge of transdermal fentanyl.
    McGregor A
    Palliat Med; 2005 Oct; 19(7):566; author reply 567-8. PubMed ID: 16295291
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians' knowledge of transdermal fentanyl.
    Lidstone V; Owen R
    Palliat Med; 2005 Oct; 19(7):566-7; author reply 567-8. PubMed ID: 16295292
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians' knowledge of transdermal fentanyl.
    Welsh J; Reid A; Graham J; Curto J; MacLeod K; O'Neill C
    Palliat Med; 2005 Jan; 19(1):9-16. PubMed ID: 15690863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
    Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
    [No Abstract]   [Full Text] [Related]  

  • 5. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.
    Breitbart W; Chandler S; Eagel B; Ellison N; Enck RE; Lefkowitz M; Payne R
    Oncology (Williston Park); 2000 May; 14(5):695-705; discussion 705, 709-17. PubMed ID: 10853461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing patient harm with the use of fentanyl transdermal system.
    Grissinger M; Gaunt MJ
    Consult Pharm; 2009 Dec; 24(12):864-72. PubMed ID: 20156000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of transdermal fentanyl patches in the effective management of cancer pain.
    Gibbs M
    Int J Palliat Nurs; 2009 Jul; 15(7):354-9. PubMed ID: 19648851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain recurrence on the third day after application of a transdermal fentanyl patch.
    Konishi H; Ishihara C; Chiba M; Endo Y; Yamaji A
    Pharm World Sci; 2005 Aug; 27(4):353. PubMed ID: 16228637
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal fentanyl for chronic pain.
    Pasero CL; McCaffery M
    Am J Nurs; 1997 Nov; 97(11):17-8. PubMed ID: 9372703
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of the clinical trial of transdermal therapeutic system-fentanyl in strong opioid pre-treated adult patients with cancer-related pain.
    Besova N; Gorbounova V; Saltanov A; Zarouk V
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():378-84. PubMed ID: 10895182
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationales behind the choice of administration form with fentanyl: Delphi survey among Danish general practitioners.
    Jacobsen R; Møldrup C; Christrup L
    J Opioid Manag; 2010; 6(4):259-68. PubMed ID: 20862906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of transdermal fentanyl in pediatric oncology palliative care.
    Noyes M; Irving H
    Am J Hosp Palliat Care; 2001; 18(6):411-6. PubMed ID: 11712724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to the use of buccal and intranasal fentanyl for breakthrough pain in paediatric palliative care: an exploratory survey.
    Harrop E; Jamieson L; Choy TH; Ho WHP; Wong ICK
    BMJ Support Palliat Care; 2018 Sep; 8(3):355-356. PubMed ID: 28801316
    [No Abstract]   [Full Text] [Related]  

  • 17. Fentanyl nasal spray (Lazanda) for pain.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):99-100. PubMed ID: 22173454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid manufacturer bribed doctors to prescribe fentanyl inappropriately, US says.
    Dyer O
    BMJ; 2016 Dec; 355():i6742. PubMed ID: 27979812
    [No Abstract]   [Full Text] [Related]  

  • 20. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.